The global proteomics market exhibits potential for significant growth and is propelled by the increasing need for personalized medicine, R&D expenditure, technological advancements, and increased funding for proteomics projects. However, a few pivotal factors hampering the growth of this market include the reduced funds in key markets, sequestration cuts in the U.S. and reduced funds for proteomics research, high cost of tools and equipment, and dearth of skilled researchers.
Download the PDF Brochure for More Details@
https://www.marketsandmarkets.com/pdfdownload.asp?id=731
Key Market Restraints:
# Sequestration Cuts in the U.S. and Reduced Funds for Proteomic Research
# Huge Disconnect Between Biomarker Discovery and Biomarker Approval By Regulatory Authorities
# Expensive Tools and Instruments and Their Maintenance
Key Market Opportunities:
# Growing Applications of Nanotechnology
# Biomarker Identification
# Untapped Emerging Markets
Key Market Challenges:
# Managing Large Volumes of Data Generated in Proteomics Research
# Dearth of Skilled Researchers and Mandatory Training Cost
In 2015, North America accounted for the largest share of the proteomics market, followed by Europe. The large share of this regional segment can be attributed to factors such as easy availability of funds from various organizations for carrying out proteomic research using innovative technologies and stringent regulatory requirements regarding pharmaceutical manufacturing. The Asia-Pacific region is expected to witness the highest growth in this market majorly due to improving biopharmaceutical research infrastructure and growing economies in Japan and India. In addition, manufacturers are increasingly focusing on strengthening their presence in emerging markets of APAC countries.
The global proteomics market is fragmented in nature. Some key players in this market are Agilent Technologies Inc. (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Bruker Corporation (U.S.), Danaher Corporation (U.S.), GE Healthcare (U.S.), Luminex Corporation (U.S.), Merck KGaA (Germany), PerkinElmer Inc. (U.S.), Thermo Fisher Scientific, Inc. (U.S.), and Waters Corporation (U.S.). These leading players have primarily focused on new product launches, acquisitions, agreements, collaboration, partnerships, and expansions for growth in the market.
Target Audience
- Proteomics Instrumentation Technology Product Manufacturers
- Researchers and Scientists
- Proteomics Industry Consulting Firms
- Proteomics Research and Development (R&D) Companies
- Healthcare Institutions
- Research Institutes
- Market Research and Consulting Firms
